StockData
Ensysce Biosciences, Inc. logo

Ensysce Biosciences, Inc. (ENSC) stock

ENSCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.38−0.03 (-6.28%)

Close on Nov 17, 2026Market cap $7.47MP/E –Yield –

Ensysce Biosciences pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Ensysce Biosciences's pe ratio was 48.4× on Oct 29, 2021.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Oct 29, 202148.4×–

More Ensysce Biosciences figures

See a number that looks wrong?